FAT1 and neoplasm: Besides, a previous study has suggested that FAT1 is a tumor suppressor or has carcinogenic effects and participates in the regulation of cell metastasis [37], but this study demonstrates that FAT1 mutation contributes to the favorable OS for DLBCL patients.